SCHEMBL22097263

SCHEMBL22097263

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc5c(c4)c4ccccc4c4cc6c7ccccc7n(-c7ccccc7)c6cc54)n3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.47
ATM Q13315 2/20 0.47
KDM4E B2RXH2 1/20 0.47
PTGER4 P35408 1/20 0.38
AVPR1A P37288 1/20 0.36
KMT2A Q03164 5/20 0.35
IL1R1 P14778 1/20 0.35
HDAC4 P56524 1/20 0.35
MEN1 O00255 4/20 0.35
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
MAT2A P31153 2/20 0.33
HSP90AA1 P07900 1/20 0.33
PRMT5 O14744 1/20 0.33
NPY5R Q15761 1/20 0.33
TSPO P30536 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22096961 1.00 L3MBTL1 (0.47) L3MBTL1ATMKDM4EPTGER4AVPR1A
SCHEMBL14728161 0.99 L3MBTL1 (0.49) L3MBTL1ATMKDM4EPTGER4AVPR1A
SCHEMBL22097078 0.99 L3MBTL1 (0.49) L3MBTL1ATMKDM4EPTGER4AVPR1A
SCHEMBL17736922 0.97 L3MBTL1 (0.44) L3MBTL1ATMKDM4EPTGER4AVPR1A
SCHEMBL17736910 0.95 L3MBTL1 (0.45) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL17736925 0.95 ATM (0.41) L3MBTL1ATMKDM4EPTGER4AVPR1A
SCHEMBL22097099 0.95 KDM4E (0.41) L3MBTL1ATMKDM4EPTGER4AVPR1A
SCHEMBL22096993 0.95 KDM4E (0.41) L3MBTL1ATMKDM4EPTGER4AVPR1A
SCHEMBL17736938 0.94 KDM4E (0.41) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL24169295 0.93 L3MBTL1 (0.49) L3MBTL1ATMKDM4EPTGER4AVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 L3MBTL1 179/4885ATM 3884/4885KDM4E 1846/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 L3MBTL1 179/4885ATM 3884/4885KDM4E 1846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.